These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 1862733

  • 1. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [Abstract] [Full Text] [Related]

  • 2. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 4. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R.
    Acta Psychiatr Scand Suppl; 1991; 365():28-32. PubMed ID: 1862731
    [Abstract] [Full Text] [Related]

  • 5. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K.
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of panic disorder patients responding to placebo.
    Rosenberg NK, Mellergård M, Rosenberg R, Beck P, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991 May; 365():33-8. PubMed ID: 1862732
    [Abstract] [Full Text] [Related]

  • 7. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 May; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 8. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA, Argyle N, Klerman GL.
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [Abstract] [Full Text] [Related]

  • 9. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 10. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB, Laraia MT, Ballenger JC, Howell EF.
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [Abstract] [Full Text] [Related]

  • 11. Patterns of response during placebo treatment of panic disorder.
    Mellergård M, Rosenberg NK.
    Acta Psychiatr Scand; 1990 Apr; 81(4):340-4. PubMed ID: 2188481
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990 Apr; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 14. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM, Prusoff B, Sholomskas AJ, Greenwald S.
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [Abstract] [Full Text] [Related]

  • 15. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL.
    J Psychiatr Res; 1990 Jun; 24 Suppl 2():27-41. PubMed ID: 1980697
    [Abstract] [Full Text] [Related]

  • 16. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 17. Validation criteria for panic disorder as a nosological entity.
    Rosenberg R, Ottosson JO, Bech P, Mellergård M, Rosenberg NK.
    Acta Psychiatr Scand Suppl; 1991 Nov; 365():7-17. PubMed ID: 1862735
    [Abstract] [Full Text] [Related]

  • 18. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
    Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF.
    J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
    [Abstract] [Full Text] [Related]

  • 19. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K, Chung HR, Csanalosi IB, Hurowitz AM, London J, Wiseman K, Kaplan M, Amsterdam JD.
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [Abstract] [Full Text] [Related]

  • 20. Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
    Maier W, Albus M, Buller R, Nutzinger D, Shera D, Bech P.
    Eur Arch Psychiatry Clin Neurosci; 1990 Oct; 240(2):103-8. PubMed ID: 2149648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.